European CPMP gives positive opinion on lamivudine for chronic hepatitis B.
Fiddian
A P
AP
Royal Free University College Medical School, London, UK. paul.fiddian@which.net
D002908:Chronic Disease; D017322:Clinical Trials, Phase II as Topic; D004279:DNA, Viral / Q000378:metabolism; D017277:Drug Approval; D005062:European Union; D006509:Hepatitis B / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D004279:DNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine